Global Influenza Drugs and Vaccines Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

SKU ID :QYR-14158449 | Published Date: 25-Jun-2019 | No. of pages: 128
Table of Contents 1 Influenza Drugs and Vaccines Market Overview 1.1 Influenza Drugs and Vaccines Product Overview 1.2 Influenza Drugs and Vaccines Market Segment by Type 1.2.1 Zanamivir 1.2.2 Oseltamivir Phosphate 1.2.3 Peramivir 1.2.4 Trivalent 1.2.5 Quadrivalent 1.3 Global Influenza Drugs and Vaccines Market Size by Type 1.3.1 Global Influenza Drugs and Vaccines Sales and Growth by Type 1.3.2 Global Influenza Drugs and Vaccines Sales and Market Share by Type (2014-2019) 1.3.3 Global Influenza Drugs and Vaccines Revenue and Market Share by Type (2014-2019) 1.3.4 Global Influenza Drugs and Vaccines Price by Type (2014-2019) 2 Global Influenza Drugs and Vaccines Market Competition by Company 2.1 Global Influenza Drugs and Vaccines Sales and Market Share by Company (2014-2019) 2.2 Global Influenza Drugs and Vaccines Revenue and Share by Company (2014-2019) 2.3 Global Influenza Drugs and Vaccines Price by Company (2014-2019) 2.4 Global Top Players Influenza Drugs and Vaccines Manufacturing Base Distribution, Sales Area, Product Types 2.5 Influenza Drugs and Vaccines Market Competitive Situation and Trends 2.5.1 Influenza Drugs and Vaccines Market Concentration Rate 2.5.2 Global Influenza Drugs and Vaccines Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Influenza Drugs and Vaccines Company Profiles and Sales Data 3.1 GlaxoSmithKline 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.1.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Sanofi Pasteur, Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.2.3 Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 CSL Limited 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.3.3 CSL Limited Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Astrazeneca 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.4.3 Astrazeneca Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Protein Sciences Corporation 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.5.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Serum Institute Of India Pvt. Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.6.3 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Emergent Biosolutions 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 Emergent Biosolutions 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.8.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 BioCryst Pharmaceuticals.Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.9.3 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Alvogen 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Influenza Drugs and Vaccines Product Category, Application and Specification 3.10.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 3.11 ABPI 4 Influenza Drugs and Vaccines Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Influenza Drugs and Vaccines Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Influenza Drugs and Vaccines Sales and Revenue by Regions 4.2.1 Global Influenza Drugs and Vaccines Sales and Market Share by Regions (2014-2019) 4.2.2 Global Influenza Drugs and Vaccines Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Influenza Drugs and Vaccines Application/End Users 5.1 Influenza Drugs and Vaccines Segment by Application 5.1.1 Hospitals 5.1.2 Research Laboratories 5.1.3 Pharmacies 5.1.4 Others 5.2 Global Influenza Drugs and Vaccines Product Segment by Application 5.2.1 Global Influenza Drugs and Vaccines Sales by Application 5.2.2 Global Influenza Drugs and Vaccines Sales and Market Share by Application (2014-2019) 6 Global Influenza Drugs and Vaccines Market Forecast 6.1 Global Influenza Drugs and Vaccines Sales, Revenue Forecast (2019-2025) 6.1.1 Global Influenza Drugs and Vaccines Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Influenza Drugs and Vaccines Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Influenza Drugs and Vaccines Forecast by Regions 6.2.1 North America Influenza Drugs and Vaccines Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Influenza Drugs and Vaccines Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Influenza Drugs and Vaccines Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Influenza Drugs and Vaccines Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Influenza Drugs and Vaccines Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Influenza Drugs and Vaccines Forecast by Type 6.3.1 Global Influenza Drugs and Vaccines Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Zanamivir Gowth Forecast 6.3.3 Oseltamivir Phosphate Gowth Forecast 6.4 Influenza Drugs and Vaccines Forecast by Application 6.4.1 Global Influenza Drugs and Vaccines Sales Forecast by Application (2019-2025) 6.4.2 Global Influenza Drugs and Vaccines Forecast in Hospitals 6.4.3 Global Influenza Drugs and Vaccines Forecast in Research Laboratories 7 Influenza Drugs and Vaccines Upstream Raw Materials 7.1 Influenza Drugs and Vaccines Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Influenza Drugs and Vaccines Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer
List of Tables and Figures Figure Influenza Drugs and Vaccines Product Picture Figure Global Influenza Drugs and Vaccines Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Influenza Drugs and Vaccines Sales (K MT) Status and Outlook (2014-2025) Figure Product Picture of Zanamivir Table Major Players of Zanamivir Figure Global Zanamivir Sales (K MT) and Growth Rate (%)(2014-2018) Figure Product Picture of Oseltamivir Phosphate Table Major Players of Oseltamivir Phosphate Figure Global Oseltamivir Phosphate Sales (K MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Peramivir Table Major Players of Peramivir Figure Global Peramivir Sales (K MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Trivalent Table Major Players of Trivalent Figure Global Trivalent Sales (K MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Quadrivalent Table Major Players of Quadrivalent Figure Global Quadrivalent Sales (K MT) and Growth Rate (%)(2014-2019) Table Global Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Comparison by Type Table Global Influenza Drugs and Vaccines Sales (K MT) by Type (2014-2019) Table Global Influenza Drugs and Vaccines Sales Share (%) by Type (2014-2019) Figure Global Influenza Drugs and Vaccines Sales Market Share (%) by Type (2014-2019) Figure Global Influenza Drugs and Vaccines Sales Market Share (%) by Type in 2018 Table Global Influenza Drugs and Vaccines Revenue (Million USD) by Type (2014-2019) Table Global Influenza Drugs and Vaccines Revenue Share (%) by Type (2014-2019) Figure Global Influenza Drugs and Vaccines Revenue Share (%) by Type (2014-2019) Figure 2018 Global Influenza Drugs and Vaccines Revenue Market Share (%) by Type Table Global Influenza Drugs and Vaccines Price (USD/MT) by Type (2014-2019) Table Global Influenza Drugs and Vaccines Sales (K MT) by Company (2014-2019) Table Global Influenza Drugs and Vaccines Sales Share (%) by Company (2014-2019) Figure Global Influenza Drugs and Vaccines Sales Share (%) by Company in 2018 Table Global Influenza Drugs and Vaccines Revenue (Million USD) by Company (2014-2019) Table Global Influenza Drugs and Vaccines Revenue Share (%) by Company (2014-2019) Figure Global Influenza Drugs and Vaccines Revenue Share (%) by Company in 2018 Table Global Market Influenza Drugs and Vaccines Average Price (USD/MT) by Company (2014-2019) Table Global Influenza Drugs and Vaccines Top Players Manufacturing Base Distribution and Sales Area Table Global Influenza Drugs and Vaccines Top Players Product Category Figure Global Influenza Drugs and Vaccines Market Share (%) of Top 5 Players Figure Global Influenza Drugs and Vaccines Market Share (%) of Top 10 Players Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Influenza Drugs and Vaccines Product Category, Application and Specification Table GlaxoSmithKline Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure GlaxoSmithKline Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure GlaxoSmithKline Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table Sanofi Pasteur, Inc. Basic Information List Figure Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Product Category, Application and Specification Table Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table CSL Limited Basic Information List Figure CSL Limited Influenza Drugs and Vaccines Product Category, Application and Specification Table CSL Limited Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure CSL Limited Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure CSL Limited Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table Astrazeneca Basic Information List Figure Astrazeneca Influenza Drugs and Vaccines Product Category, Application and Specification Table Astrazeneca Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Astrazeneca Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure Astrazeneca Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table Protein Sciences Corporation Basic Information List Figure Protein Sciences Corporation Influenza Drugs and Vaccines Product Category, Application and Specification Table Protein Sciences Corporation Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Protein Sciences Corporation Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure Protein Sciences Corporation Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table Serum Institute Of India Pvt. Ltd. Basic Information List Figure Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Product Category, Application and Specification Table Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table Emergent Biosolutions Basic Information List Figure Emergent Biosolutions Influenza Drugs and Vaccines Product Category, Application and Specification Table Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table Emergent Biosolutions Basic Information List Figure Emergent Biosolutions Influenza Drugs and Vaccines Product Category, Application and Specification Table Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table BioCryst Pharmaceuticals.Inc. Basic Information List Figure BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Product Category, Application and Specification Table BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table Alvogen Basic Information List Figure Alvogen Influenza Drugs and Vaccines Product Category, Application and Specification Table Alvogen Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Alvogen Influenza Drugs and Vaccines Sales Growth Rate (2014-2019) Figure Alvogen Influenza Drugs and Vaccines Sales Global Market Share (%)(2014-2019) Table ABPI Basic Information List Table Global Influenza Drugs and Vaccines Market Size Comparison by Regions (2014-2025) Figure North America Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Influenza Drugs and Vaccines Sales (K MT) by Regions (2014-2019) Table Global Influenza Drugs and Vaccines Sales Market Share (%) by Regions (2014-2019) Figure Global Influenza Drugs and Vaccines Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Influenza Drugs and Vaccines Sales Market Share (%) by Regions Table Global Influenza Drugs and Vaccines Revenue (Million USD) by Regions (2014-2019) Table Global Influenza Drugs and Vaccines Revenue Market Share (%) by Regions (2014-2019) Figure Global Influenza Drugs and Vaccines Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Influenza Drugs and Vaccines Revenue Market Share (%) by Regions Table Global Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure North America Influenza Drugs and Vaccines Sales Growth Rate Table North America Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure United States Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure United States Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Canada Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Canada Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Mexico Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Mexico Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Europe Influenza Drugs and Vaccines Sales Growth Rate Table Europe Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Germany Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Germany Influenza Drugs and Vaccines Revenue (Million USD) (2014-2019) Figure UK Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure UK Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure France Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure France Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Italy Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Italy Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Russia Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Russia Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Turkey Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Turkey Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Asia-Pacific Influenza Drugs and Vaccines Sales Growth Rate Table Asia-Pacific Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure China Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure China Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Japan Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Japan Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Korea Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Korea Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Southeast Asia Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Southeast Asia Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Indonesia Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Indonesia Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Thailand Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Thailand Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Malaysia Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Malaysia Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Philippines Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Philippines Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Vietnam Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Vietnam Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure India Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure India Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Australia Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Australia Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure South America Influenza Drugs and Vaccines Sales Growth Rate Table South America Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Brazil Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure Brazil Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Middle East and Africa Influenza Drugs and Vaccines Sales Growth Rate Table Middle East and Africa Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure North Africa Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure North Africa Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure GCC Countries Influenza Drugs and Vaccines Sales (K MT)(2014-2019) Figure GCC Countries Influenza Drugs and Vaccines Revenue (Million USD)(2014-2019) Figure Hospitals Examples Figure Research Laboratories Examples Figure Pharmacies Examples Figure Others Examples Table Global Influenza Drugs and Vaccines Sales (K MT) Comparison by Application (2014-2025) Table Global Influenza Drugs and Vaccines Sales (K MT) by Application (2014-2019) Table Global Influenza Drugs and Vaccines Sales Share (%) by Application (2014-2019) Figure Global Influenza Drugs and Vaccines Sales Market Share (%) by Application (2014-2019) Figure Global Influenza Drugs and Vaccines Sales Market Share (%) by Application in 2018 Figure Global Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Global Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Influenza Drugs and Vaccines Sales (K MT) Forecast by Regions (2019-2025) Figure Global Influenza Drugs and Vaccines Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure North America Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Europe Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure China Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Japan Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Korea Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure India Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Australia Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure South America Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Influenza Drugs and Vaccines Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Influenza Drugs and Vaccines Sales (Million USD) Forecast by Type (2019-2025) Figure Global Influenza Drugs and Vaccines Sales Market Share (%) Forecast by Type (2019-2025) Table Global Influenza Drugs and Vaccines Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Influenza Drugs and Vaccines Revenue Market Share (%) Forecast by Type (2019-2025) Figure Zanamivir Sales Growth Forecast Figure Oseltamivir Phosphate Sales Growth Forecast Table Global Influenza Drugs and Vaccines Sales (K MT) Forecast by Application (2019-2025) Figure Global Influenza Drugs and Vaccines Sales Forecast by Application (2019-2025) Figure Global Influenza Drugs and Vaccines Sales (K MT) Forecast in Hospitals Figure Global Influenza Drugs and Vaccines Sales (K MT) Forecast in Research Laboratories Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Influenza Drugs and Vaccines Manufacturing Cost Structure Figure Influenza Drugs and Vaccines Industrial Chain Analysis Table Distributors List Table Influenza Drugs and Vaccines Downstream Customers
GlaxoSmithKline Sanofi Pasteur, Inc. CSL Limited Astrazeneca Protein Sciences Corporation Serum Institute Of India Pvt. Ltd. Emergent Biosolutions Emergent Biosolutions BioCryst Pharmaceuticals.Inc. Alvogen ABPI
  • PRICE
  • $3350
    $6700

Our Clients